Abstract
Cancer and coronary artery disease, both leading global causes of mortality, share common risk factors and are exacerbated by various cancer treatments. Coronary artery disease may delay cancer treatment initiation. Revascularization improves the safety of subsequent cancer treatment and long-term survival. Radiation commonly induces ostial coronary artery disease due to its proximity to the mediastinum, while ostial coronary artery disease related to chemotherapy is rarely reported. In this case, we explore an instance of Serous cystadenocarcinoma of the ovary, treated with Neo Adjuvant chemotherapy based on Paclitaxel, subsequently presented with ostial coronary artery disease, leading to cardiogenic shock and heart failure. The condition was successfully managed through bailed out angioplasty, followed by debulking oophorectomy surgery. The patient was under regular follow up for the past 3 years.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
